Literature DB >> 24472717

A "window of opportunity" for patients with late-onset pulmonary dysfunction after allogeneic hematopoietic cell transplantation.

Kenneth R Cooke1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24472717      PMCID: PMC4399635          DOI: 10.1016/j.bbmt.2014.01.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  12 in total

1.  What we know and mostly do not know about bronchiolitis obliterans syndrome.

Authors:  P J Martin; J W Chien
Journal:  Bone Marrow Transplant       Date:  2012-01       Impact factor: 5.483

2.  Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.

Authors:  Ami S Bhatt; Samuel S Freeman; Alex F Herrera; Chandra Sekhar Pedamallu; Dirk Gevers; Fujiko Duke; Joonil Jung; Monia Michaud; Bruce J Walker; Sarah Young; Ashlee M Earl; Aleksander D Kostic; Akinyemi I Ojesina; Robert Hasserjian; Karen K Ballen; Yi-Bin Chen; Gabriela Hobbs; Joseph H Antin; Robert J Soiffer; Lindsey R Baden; Wendy S Garrett; Jason L Hornick; Francisco M Marty; Matthew Meyerson
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

Review 3.  Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.

Authors:  Salyka M Sengsayadeth; Shivani Srivastava; Madan Jagasia; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-24       Impact factor: 5.742

4.  Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.

Authors:  Gregory A Yanik; Shin Mineishi; John E Levine; Carrie L Kitko; Eric S White; Mark T Vander Lugt; Andrew C Harris; Thomas Braun; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

5.  Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

Authors:  Jeanne Palmer; Kirsten Williams; Yoshihiro Inamoto; Xiaoyu Chai; Paul J Martin; Linus Santo Tomas; Corey Cutler; Daniel Weisdorf; Brenda F Kurland; Paul A Carpenter; Joseph Pidala; Steven Z Pavletic; William Wood; David Jacobsohn; Sally Arai; Mukta Arora; Madan Jagasia; Georgia B Vogelsang; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-04       Impact factor: 5.742

6.  A new murine model for bronchiolitis obliterans post-bone marrow transplant.

Authors:  Angela Panoskaltsis-Mortari; Kevin V Tram; Andrew P Price; Christine H Wendt; Bruce R Blazar
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

7.  Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Jason W Chien; Mark T Gladwin; Steven Z Pavletic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

8.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

Review 9.  Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.

Authors:  Satoshi Yoshihara; Gregory Yanik; Kenneth R Cooke; Shin Mineishi
Journal:  Biol Blood Marrow Transplant       Date:  2007-07       Impact factor: 5.742

Review 10.  Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.

Authors:  G C Hildebrandt; T Fazekas; A Lawitschka; H Bertz; H Greinix; J Halter; S Z Pavletic; E Holler; D Wolff
Journal:  Bone Marrow Transplant       Date:  2011-03-28       Impact factor: 5.483

View more
  5 in total

1.  Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry.

Authors:  Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods
Journal:  Eur Respir J       Date:  2019-05-02       Impact factor: 16.671

2.  Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.

Authors:  Ajay Sheshadri; Mahtab Karimipour; Erik Vakil; Lara Bashoura; Myrna Godoy; Muhammad H Arain; Scott E Evans; Burton F Dickey; David E Ost; Roy F Chemaly; Saadia A Faiz
Journal:  Transpl Infect Dis       Date:  2019-05-28       Impact factor: 2.228

3.  Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Guang-Shing Cheng; Angela P Campbell; Hu Xie; Zach Stednick; Cheryl Callais; Wendy M Leisenring; Janet A Englund; Jason W Chien; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-31       Impact factor: 5.742

4.  Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.

Authors:  Guang-Shing Cheng; Barry Storer; Jason W Chien; Madan Jagasia; Jesse J Hubbard; Linda Burns; Vincent T Ho; Joseph Pidala; Jeanne Palmer; Laura Johnston; Sebastian Mayer; Kristina Crothers; Iskra Pusic; Stephanie J Lee; Kirsten M Williams
Journal:  Ann Am Thorac Soc       Date:  2016-11

5.  Pulmonary surveillance in pediatric hematopoietic stem cell transplant: A multinational multidisciplinary survey.

Authors:  Shivanthan Shanthikumar; William A Gower; Matthew Abts; Deborah R Liptzin; Elizabeth K Fiorino; Anne Stone; Saumini Srinivasan; Timothy J Vece; Nour Akil; Theresa Cole; Kenneth R Cooke; Samuel B Goldfarb
Journal:  Cancer Rep (Hoboken)       Date:  2021-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.